# BridgeBio Pharma, Inc. – aktieanalysens källarkiv

Company page: https://spela.port0.org/company/bridgebio-pharma-inc
Company JSON: https://spela.port0.org/company/bridgebio-pharma-inc/company.json
Documents JSON: https://spela.port0.org/company/bridgebio-pharma-inc/documents.json
Updated: 2026-08-06T06:41:33Z

## Market data
- Nasdaq kurshistorik CSV: https://spela.port0.org/company/bridgebio-pharma-inc/market/history.csv
- Nasdaq kurshistorik JSON: https://spela.port0.org/company/bridgebio-pharma-inc/market/history.json
- Nasdaq manifest JSON: https://spela.port0.org/company/bridgebio-pharma-inc/market/manifest.json
- SEC Company Facts JSON: https://spela.port0.org/company/bridgebio-pharma-inc/market/sec-companyfacts.json
- SEC filing-manifest JSON: https://spela.port0.org/company/bridgebio-pharma-inc/market/sec-manifest.json
- SEC sammanfattning JSON: https://spela.port0.org/company/bridgebio-pharma-inc/market/sec-summary.json

## Full-text source documents
- SEC EDGAR | 8-K – 2026-07-22 – ef20078442_form8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-07-22-ef20078442-form8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-07-02 – ef20077282_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-07-02-ef20077282-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-06-26 – ef20076710_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-06-26-ef20076710-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-27 – ef20074977_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-05-27-ef20074977-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-13 – ef20073370_form8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-05-13-ef20073370-form8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-08 – ny20072667x2_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-05-08-ny20072667x2-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-05-07 – bbio-20260506.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-05-07-bbio-20260506-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2026-05-07 – bbio-20260331.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2026-05-07-bbio-20260331-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2026-05-07-bbio-20260331-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2026-05-07-bbio-20260331-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2026-05-07-bbio-20260331-htm/part-003.html
  - HTML part 4: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2026-05-07-bbio-20260331-htm/part-004.html
- SEC EDGAR | 8-K – 2026-03-30 – ef20069329_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-03-30-ef20069329-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-02-24 – bbio-20260224.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-02-24-bbio-20260224-htm/fulltext.txt
- SEC EDGAR | 10-K – 2026-02-24 – bbio-20251231.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-003.html
  - HTML part 4: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-004.html
  - HTML part 5: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-005.html
  - HTML part 6: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-k-2026-02-24-bbio-20251231-htm/part-006.html
- SEC EDGAR | 8-K – 2026-02-12 – ef20065539_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-02-12-ef20065539-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-01-21 – ef20063486_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-01-21-ef20063486-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2026-01-12 – ef20062706_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2026-01-12-ef20062706-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-10-29 – ef20057894_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2025-10-29-ef20057894-8k-htm/fulltext.txt
- SEC EDGAR | 8-K – 2025-10-29 – bbio-20251029.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2025-10-29-bbio-20251029-htm/fulltext.txt
- SEC EDGAR | 10-Q – 2025-10-29 – bbio-20250930.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2025-10-29-bbio-20250930-htm/fulltext.txt
  - HTML part 1: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2025-10-29-bbio-20250930-htm/part-001.html
  - HTML part 2: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2025-10-29-bbio-20250930-htm/part-002.html
  - HTML part 3: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-10-q-2025-10-29-bbio-20250930-htm/part-003.html
- SEC EDGAR | 8-K – 2025-10-27 – ef20057750_8k.htm: https://spela.port0.org/company/bridgebio-pharma-inc/documents/sec-edgar-8-k-2025-10-27-ef20057750-8k-htm/fulltext.txt